Literature DB >> 23589539

A clinical opportunity for routine HIV testing.

Richard Long, Deanne Langlois-Klassen.   

Abstract

Mesh:

Year:  2013        PMID: 23589539      PMCID: PMC3626813          DOI: 10.1503/cmaj.113-2113

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts.

Authors:  Richard Long; Stan Houston; Earl Hershfield
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

2.  High HIV-TB co-infection rates in marginalized populations: evidence from Alberta in support of screening TB patients for HIV.

Authors:  Richard Long; Jody Boffa
Journal:  Can J Public Health       Date:  2010 May-Jun

3.  Seek and treat to optimize HIV and AIDS prevention.

Authors:  Réka Gustafson; Julio Montaner; Barbara Sibbald
Journal:  CMAJ       Date:  2012-11-26       Impact factor: 8.262

4.  The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in Alberta.

Authors:  Doris Sturtevant; Jutta Preiksaitis; Ameeta Singh; Stan Houston; John Gill; Gerry Predy; Dina Fisher; Ambikaipakan Senthilselvan; Jure Manfreda; Jody Boffa; Richard Long
Journal:  Can J Public Health       Date:  2009 Mar-Apr

5.  Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and human immunodeficiency virus infection. Canadian Thoracic Society, the Tuberculosis Directors of Canada and the Department of National Health and Welfare.

Authors: 
Journal:  Can Commun Dis Rep       Date:  1992-10-30
  5 in total
  1 in total

1.  A 10-year population based study of 'opt-out' HIV testing of tuberculosis patients in Alberta, Canada: national implications.

Authors:  Richard Long; Selvanayagam Niruban; Courtney Heffernan; Ryan Cooper; Dina Fisher; Rabia Ahmed; Mary Lou Egedahl; Rhonda Fur
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.